Qiagen company profile
Company profile
Qiagen has 5,400 employees and is headquartered in Venlo, Netherlands.
Laboratories in molecular diagnostics and life sciences research worldwide use the products of Qiagen N.V., which turns biological samples into molecular insights. Its range covers sample technology consumables such as nucleic acid purification kits and instruments, assays for infectious disease, oncology and sexual and reproductive health testing, research PCR and digital PCR solutions, NGS gene panels and library prep kits, DNA methylation analysis, human ID and forensics assays, and bioinformatics software delivered as a service.
In the fiscal year ended December 2025, revenue reached 2.1 billion US dollars, up 5.7% from the previous year, and net profit amounted to 424.9 million US dollars. The company employed 5,400 people and is headquartered in Venlo, the Netherlands, where it was founded in 1984.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Germany
- Headquarters
- Hulsterweg 82, 5912 PL, Venlo
- Employees
- 5,400
- Listing
- QIA · Xetra
- Indices
- DAX
- Currency
- EUR
- ISIN
- NL0015002SN0
- Website
- qiagen.com
Qiagen and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| QiagenQIA | Germany | $10.3B | 5,400 | 26.7% | 27.3 |
| bioMérieuxBIM | France | $11.7B | 14,562 | 16.0% | 23.2 |
| Eurofins ScientificERF | France | $16.53B | 65,000 | 14.1% | 30.5 |
| DiaSorinDIA | Italy | $4.56B | 3,212 | 22.3% | 31.0 |
| Lonza GroupLONN | Switzerland | $55.11B | 20,141 | 23.5% | 43.9 |
| DiagnostykaDIA | Poland | $1.29B | 8,645 | 14.9% | 20.3 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
